Articles

Search Imperial News

Showing 115 results

Clear Filters

Health

A life in paediatric HIV research and care: Prof Gareth Tudor-Williams retires

5 October 2021

Health

New vaccine study to investigate durability of COVID-19 immunity

26 August 2021

Engineering

Histamine could be a key player in depression, according to study in mice

17 August 2021

Health

Third mRNA COVID vaccine dose could benefit immunocompromised dialysis patients

12 August 2021

Health

Blood clots in severe COVID cases may be related to abnormal antibody response

30 July 2021

Health

New study sheds light on link between joint injury and osteoarthritis

21 July 2021

Health

Long COVID: Unpicking the lasting impact of COVID-19

18 July 2021

Health

First major study of new HIV therapy opens to recruitment

1 July 2021

Health

Key enzyme aggravates colorectal cancer in obese patients

28 May 2021

Health

Key enzyme TPL-2 helps immune cells kill disease-causing bacteria

30 April 2021

Health

Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose

30 April 2021

Health

New study reveals weak spots in chemotherapy-resistant cancer cells

27 April 2021

Health

Coloured compounds may help coronavirus evade antibodies

23 April 2021

Health

UK researchers identify inflammatory protein linked to severe COVID-19

10 March 2021

Health

New study to explore how well COVID-19 vaccines protect dialysis patients

5 March 2021

Imperial news

10 times Imperial made us smile in 2020

26 December 2020

Health

COVID-19 immunity lasts over 4 months, but antibody and T cells can “uncouple"

23 December 2020

Engineering

Q&A: Cold chains, COVID-19 vaccines and reaching low-income countries

2 December 2020

Health

New anti-cancer drug combo treatment shows promise for myeloma patients

12 November 2020

Imperial news

Cannabis pain insights and kidney disease discoveries: News from the College

23 October 2020

Imperial College London

Latest News

Imperial News

Articles

Search Imperial News

A life in paediatric HIV research and care: Prof Gareth Tudor-Williams retires

New vaccine study to investigate durability of COVID-19 immunity

Histamine could be a key player in depression, according to study in mice

Third mRNA COVID vaccine dose could benefit immunocompromised dialysis patients

Blood clots in severe COVID cases may be related to abnormal antibody response

New study sheds light on link between joint injury and osteoarthritis

Long COVID: Unpicking the lasting impact of COVID-19

First major study of new HIV therapy opens to recruitment

Key enzyme aggravates colorectal cancer in obese patients

Key enzyme TPL-2 helps immune cells kill disease-causing bacteria

Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose

New study reveals weak spots in chemotherapy-resistant cancer cells

Coloured compounds may help coronavirus evade antibodies

UK researchers identify inflammatory protein linked to severe COVID-19

New study to explore how well COVID-19 vaccines protect dialysis patients

10 times Imperial made us smile in 2020

COVID-19 immunity lasts over 4 months, but antibody and T cells can “uncouple"

Q&A: Cold chains, COVID-19 vaccines and reaching low-income countries

New anti-cancer drug combo treatment shows promise for myeloma patients

Cannabis pain insights and kidney disease discoveries: News from the College

Articles

Search Imperial News

Refine your results

A life in paediatric HIV research and care: Prof Gareth Tudor-Williams retires

New vaccine study to investigate durability of COVID-19 immunity

Histamine could be a key player in depression, according to study in mice

Third mRNA COVID vaccine dose could benefit immunocompromised dialysis patients

Blood clots in severe COVID cases may be related to abnormal antibody response

New study sheds light on link between joint injury and osteoarthritis

Long COVID: Unpicking the lasting impact of COVID-19

First major study of new HIV therapy opens to recruitment

Key enzyme aggravates colorectal cancer in obese patients

Key enzyme TPL-2 helps immune cells kill disease-causing bacteria

Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose

New study reveals weak spots in chemotherapy-resistant cancer cells

Coloured compounds may help coronavirus evade antibodies

UK researchers identify inflammatory protein linked to severe COVID-19

New study to explore how well COVID-19 vaccines protect dialysis patients

10 times Imperial made us smile in 2020

COVID-19 immunity lasts over 4 months, but antibody and T cells can “uncouple"

Q&A: Cold chains, COVID-19 vaccines and reaching low-income countries

New anti-cancer drug combo treatment shows promise for myeloma patients

Cannabis pain insights and kidney disease discoveries: News from the College